Akkaraju Srinivas
Director at ALMS; Director at SYRS; Director at SRRK, and 3 more
- Sold, on record
- $96.8M
- Dollars the filings state
- Form 4 sales
- 26
- Latest Sep 8, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 6
- Filed as an executive or holder
Companies
- ALMSALUMIS INC.Director
- SYRSSyros Pharmaceuticals, Inc.Director
- SRRKScholar Rock Holding CorpDirector
- Seagen Inc.Director
- INTERCEPT PHARMACEUTICALS INCDirector
- TRIMERIS INCOther
Sales by reason
1
Routine
18
Plan not stated
1
No plan
6
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- Seagen Inc.2.7M shares
- SRRK1.2M shares
- TRIMERIS INC684,556 shares
- SYRS318,654 shares
- ALMS96,131 shares
- INTERCEPT PHARMACEUTICALS INC26,948 shares
Shares sold, every Form 4 sale on record.
Timeline
- Sep 8, 2026No plan
Sold 4.5% of their holdings
$1M96,131 shares at $10.55
- Dec 30, 2024Notice
Filed a notice to sell 9,333 shares
$2k9,333 shares
- Oct 7, 2024Notice
Filed a notice to sell 1.2M shares
$34.4M1.2M shares
- Oct 7, 2024Routine
Sold 17.3% of their holdings
$34.4M1.2M shares at $29.25
- Aug 18, 2020Plan not stated
Sold 11.1% of their holdings
$2.1M159,327 shares at $13.10
- Jul 1, 2020Plan not stated
Sold 0.3% of their holdings
$51k4,627 shares at $11.01
- Jun 25, 2020Plan not stated
Sold 9.7% of their holdings
$1.7M154,700 shares at $11.11
- May 5, 2020Plan not stated
Sold 17.5% of their holdings
$1.4M8,500 shares at $167.26
- Nov 21, 2019Unusual
Sold 30.3% of their holdings
$2.1M17,500 shares at $119.78
- Feb 19, 2019Plan not stated
Sold 10% of their holdings
$3M23,438 shares at $128.78
10 of 28
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 9, 2026 | ALMS | Director | Form 4 sale | 96,131 | $1M | 4.5% | No plan | SEC |
| Dec 30, 2024 | Dec 30, 2024 | SYRS | Director | Form 144 notice | 9,333 | $2k | Notice | SEC | |
| Oct 7, 2024 | Oct 7, 2024 | SRRK | Director | Form 144 notice | 1.2M | $34.4M | Notice | SEC | |
| Oct 7, 2024 | Oct 7, 2024 | SRRK | Director | Form 4 sale | 1.2M | $34.4M | 17.3% | Routine | SEC |
| Aug 18, 2020 | Aug 19, 2020 | SYRS | Director | Form 4 sale | 159,327 | $2.1M | 11.1% | Plan not stated | SEC |
| Jul 1, 2020 | Jul 6, 2020 | SYRS | Director | Form 4 sale | 4,627 | $51k | 0.3% | Plan not stated | SEC |
| Jun 25, 2020 | Jun 25, 2020 | SYRS | Director | Form 4 sale | 154,700 | $1.7M | 9.7% | Plan not stated | SEC |
| May 5, 2020 | May 7, 2020 | Seagen Inc. | Director | Form 4 sale | 8,500 | $1.4M | 17.5% | Plan not stated | SEC |
| Nov 21, 2019 | Nov 22, 2019 | Seagen Inc. | Director | Form 4 sale | 17,500 | $2.1M | 30.3% | Unusual | SEC |
| Feb 19, 2019 | Feb 21, 2019 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 23,438 | $3M | 10.0% | Plan not stated | SEC |
| Jan 16, 2014 | Jan 17, 2014 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 3,250 | $871k | 62.6% | Unusual | SEC |
| Dec 18, 2013 | Dec 19, 2013 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 260 | $14k | 9.9% | Plan not stated | SEC |
| Jun 14, 2013 | Jun 17, 2013 | Seagen Inc. | Director | Form 4 sale | 5,000 | $164k | 26.4% | Unusual | SEC |
| May 10, 2013 | May 14, 2013 | Seagen Inc. | Director | Form 4 sale | 17,500 | $650k | 62.7% | Unusual | SEC |
| Jun 27, 2012 | Jun 28, 2012 | TRIMERIS INC | Other | Form 4 sale | 342,278 | $13.6M | 25.0% | Unusual | SEC |
| Mar 19, 2012 | Mar 21, 2012 | TRIMERIS INC | Director | Form 4 sale | 342,278 | $11.1M | 20.0% | Plan not stated | SEC |
| Sep 22, 2008 | Sep 23, 2008 | Seagen Inc. | Director | Form 4 sale | 18,601 | $238k | 3.0% | Plan not stated | SEC |
| Sep 19, 2008 | Sep 22, 2008 | Seagen Inc. | Director | Form 4 sale | 37,011 | $472k | 5.8% | Plan not stated | SEC |
| Sep 18, 2008 | Sep 19, 2008 | Seagen Inc. | Director | Form 4 sale | 20,839 | $265k | 3.3% | Plan not stated | SEC |
| Jul 29, 2008 | Jul 30, 2008 | Seagen Inc. | Director | Form 4 sale | 95,688 | $1M | 13.3% | Plan not stated | SEC |
| Jul 28, 2008 | Jul 29, 2008 | Seagen Inc. | Director | Form 4 sale | 21,232 | $220k | 3.0% | Plan not stated | SEC |
| Jul 25, 2008 | Jul 28, 2008 | Seagen Inc. | Director | Form 4 sale | 148,136 | $1.6M | 17.4% | Plan not stated | SEC |
| May 16, 2008 | May 19, 2008 | Seagen Inc. | Director | Form 4 sale | 42,059 | $437k | 4.9% | Plan not stated | SEC |
| May 15, 2008 | May 19, 2008 | Seagen Inc. | Director | Form 4 sale | 98,758 | $1M | 10.5% | Plan not stated | SEC |
| May 14, 2008 | May 15, 2008 | Seagen Inc. | Director | Form 4 sale | 121,365 | $1.2M | 11.7% | Plan not stated | SEC |
| May 13, 2008 | May 15, 2008 | Seagen Inc. | Director | Form 4 sale | 50,896 | $512k | 4.8% | Plan not stated | SEC |
| Dec 10, 2007 | Dec 12, 2007 | Seagen Inc. | Director | Form 4 sale | 20,960 | $265k | 2.0% | Plan not stated | SEC |
| Feb 9, 2007 | Feb 14, 2007 | Seagen Inc. | Director | Form 4 sale | 2M | $17.3M | 100.0% | Unusual | SEC |